News and Blog

News and Blog



Call to Action

Call to Action

On 21st January, in the House of Commons, Geoffrey Clifton-Brown MP chaired a discussion with Empower: Access to Medicine and the Health Minister, Earl Howe. Leading minds from the medical, political, pharmaceutical and patient advocacy world came together to debate the barriers that prevent medicines from getting to those who need it.

We are currently in the process of producing a report summarizing the discussion, so keep an eye out for it on our news page. In the meantime you can read this blog by Steve Bates, CEO of the BioIndustry Association, who took part in the debate.

Although the Minister was clear in his commitment to life sciences and admitted his frustration at the pace of progress, what was less clear was the timescales behind the Government’s ambition for accelerated access. The fact remains that lives are at stake while we wait for action.

How do we make progress?

We need to demonstrate to the Government and Parliament that this is more than a policy issue; the lack of progress in drug development affects real people and real lives.

That is why we are hosting a lobby of Parliament on 25th March in the House of Commons 4pm-6pm. We are looking for patients, and/or their families, to attend with their constituent MP so that we can get this issue onto the agenda of backbenchers.

If you would like to get involved, or support the event financially please contact the campaign team through the website

This lobby of Parliament will hear from leading politicians, pharmaceuticals and patient advocates to explain how and why things can be done differently.

It is through educating our elected representatives that we can really bring pressure to bear to ensure that we change the system for the better.


    Add your comment

    Please enter the word you see in the image below:


    Recent Articles

    Latest Tweets

    Press Enquiries

    Please contact James Hargrave at JBP PR or telephone 0203 267 0074 for any press or event related enquiries.